GDC-0927
GDC-0927 (SRN-927) is a potent, non-steroidal, orally bioavailable, selective estrogen receptor antagonist[1].
Product Specifications
CAS Number
1642297-01-5
Product Name Alternative
SRN-927
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
Estrogen Receptor/ERR
Type
Reference compound
Related Pathways
Vitamin D Related/Nuclear Receptor
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/GDC-0927.html
Purity
99.98
Solubility
DMSO : 83.33 mg/mL (ultrasonic)
Smiles
OC1=CC=C2C(C(C)=C(C3=CC=CC(O)=C3)[C@H](C4=CC=C(OCCN5CC(CF)C5)C=C4)O2)=C1
Molecular Formula
C28H28FNO4
Molecular Weight
461.52
Precautions
H302, H315, H319, H335
References & Citations
[1]MN Dickler, et al. Abstract PD5-10: A first-in-human phase I study to evaluate the oral selective estrogen receptor degrader (SERD), GDC-0927, in postmenopausal women with estrogen receptor positive (ER+) HER2-negative metastatic breast cancer (BC) . AACR; Cancer Res 2018;78 (4 Suppl) :Abstract nr PD5-10.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TL504681V 500 µL Each
Urgcp Mouse shRNA Lentiviral Particle (Locus ID 72046)
Sign In for Pricing
View Details 246182-ML550 100 µL
FLJ20643 (PIH1 Domain Containing 1, FLJ20643, NOP17) (MaxLight 550)
Sign In for Pricing
View Details 
![Cucurbit[7]uril](https://cdn.genprice.uk/genprice/uk/genprice3.webp)